Cargando…

Decreased KPNB1 Expression is Induced by PLK1 Inhibition and Leads to Apoptosis in Lung Adenocarcinoma

Lung cancer is a major cause of death worldwide, with lung adenocarcinoma being the most frequently diagnosed subtype in Japan. Finding the target of an anticancer drug can improve lung adenocarcinoma treatments. Polo-like kinase 1 (PLK1) is an essential mitotic kinase in mitotic progression, and PL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sekimoto, Noboru, Suzuki, Yutaka, Sugano, Sumio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706017/ https://www.ncbi.nlm.nih.gov/pubmed/29187890 http://dx.doi.org/10.7150/jca.21802

Ejemplares similares

Expression of miR-26a exhibits a negative correlation with HMGA1 and regulates cancer progression by targeting HMGA1 in lung adenocarcinoma cells
por: Sekimoto, Noboru, et al.
Publicado: (2017)

KPNB1 inhibition disrupts proteostasis and triggers unfolded protein response-mediated apoptosis in glioblastoma cells
por: Zhu, Zhi-Chuan, et al.
Publicado: (2018)

Inhibition of KPNB1 Inhibits Proliferation and Promotes Apoptosis of Chronic Myeloid Leukemia Cells Through Regulation of E2F1
por: Wang, Teng, et al.
Publicado: (2019)

PCDH1 promotes progression of pancreatic ductal adenocarcinoma via activation of NF-κB signalling by interacting with KPNB1
por: Ye, Zhihua, et al.
Publicado: (2022)

KPNB1 mediates PER/CRY nuclear translocation and circadian clock function
por: Lee, Yool, et al.
Publicado: (2015)

Single-cell analysis of lung adenocarcinoma cell lines reveals diverse expression patterns of individual cells invoked by a molecular target drug treatment
por: Suzuki, Ayako, et al.
Publicado: (2015)

Targeting KPNB1 overcomes TRAIL resistance by regulating DR5, Mcl-1 and FLIP in glioblastoma cells
por: Zhu, Zhi-Chuan, et al.
Publicado: (2019)

Aberrant transcriptional regulations in cancers: genome, transcriptome and epigenome analysis of lung adenocarcinoma cell lines
por: Suzuki, Ayako, et al.
Publicado: (2014)

Unconventional tonicity-regulated nuclear trafficking of NFAT5 mediated by KPNB1, XPOT and RUVBL2
por: Cheung, Chris Y., et al.
Publicado: (2022)

Identification of potential regulatory mutations using multi-omics analysis and haplotyping of lung adenocarcinoma cell lines
por: Sereewattanawoot, Sarun, et al.
Publicado: (2018)

KPNB1-mediated nuclear import is required for motility and inflammatory transcription factor activity in cervical cancer cells
por: Stelma, Tamara, et al.
Publicado: (2017)

KPNB1 modulates the Machado–Joseph disease protein ataxin-3 through activation of the mitochondrial protease CLPP
por: Abeditashi, Mahkameh, et al.
Publicado: (2022)

PLK1 Is a Potential Prognostic Factor Associated with the Tumor Microenvironment in Lung Adenocarcinoma
por: Wang, Lina, et al.
Publicado: (2022)

The FOXM1-PLK1 axis is commonly upregulated in oesophageal adenocarcinoma
por: Dibb, M, et al.
Publicado: (2012)

Integrated bioinformatics analysis reveals CDK1 and PLK1 as potential therapeutic targets of lung adenocarcinoma
por: Li, Shuzhen, et al.
Publicado: (2021)

KPNB1 Inhibitor Importazole Reduces Ionizing Radiation-Increased Cell Surface PD-L1 Expression by Modulating Expression and Nuclear Import of IRF1
por: Yoshino, Hironori, et al.
Publicado: (2021)

Identification and Characterization of Cancer Mutations in Japanese Lung Adenocarcinoma without Sequencing of Normal Tissue Counterparts
por: Suzuki, Ayako, et al.
Publicado: (2013)

Characterization of STAT6 Target Genes in Human B Cells and Lung Epithelial Cells
por: Kanai, Akinori, et al.
Publicado: (2011)

Retracted: PLK1 Is a Potential Prognostic Factor Associated with the Tumor Microenvironment in Lung Adenocarcinoma
por: International, BioMed Research
Publicado: (2023)

Antitumor effects of pharmacological EZH2 inhibition on malignant peripheral nerve sheath tumor through the miR-30a and KPNB1 pathway
por: Zhang, Pingyu, et al.
Publicado: (2015)

Plk1 is upregulated in androgen-insensitive prostate cancer cells and its inhibition leads to necroptosis
por: Deeraksa, Arpaporn, et al.
Publicado: (2012)

High in vitro and in vivo synergistic activity between mTORC1 and PLK1 inhibition in adenocarcinoma NSCLC
por: Montaudon, Elodie, et al.
Publicado: (2021)

The expression and clinical significance of PLK1/p-PLK1 protein in NK/T cell Lymphoma
por: Zhang, Zhiqi, et al.
Publicado: (2023)

Sepsis induces muscle atrophy by inhibiting proliferation and promoting apoptosis via PLK1‐AKT signalling
por: Cao, Ying‐Ya, et al.
Publicado: (2021)

KPNB1-mediated nuclear translocation of PD-L1 promotes non-small cell lung cancer cell proliferation via the Gas6/MerTK signaling pathway
por: Du, Wenwen, et al.
Publicado: (2020)

Pharmacological inhibition of Polo-like kinase 1 (PLK1) by BI-2536 decreases the viability and survival of hamartin and tuberin deficient cells via induction of apoptosis and attenuation of autophagy
por: Valianou, Matthildi, et al.
Publicado: (2015)

Knockdown of actin-like 8 inhibits cell proliferation by regulating FOXM1, STMN1, PLK1, and BIRC5 in lung adenocarcinoma A549 cells
por: Ma, Shanwu, et al.
Publicado: (2019)

PLK1 inhibition promotes apoptosis and DNA damage in glioma stem cells by regulating the nuclear translocation of YBX1
por: Li, Xuetao, et al.
Publicado: (2023)

Exploration of the Combination of PLK1 Inhibition with Immunotherapy in Cancer Treatment
por: Li, Mengyuan, et al.
Publicado: (2018)

Combinatorial Effect of PLK1 Inhibition with Temozolomide and Radiation in Glioblastoma
por: Pandey, Arvind, et al.
Publicado: (2021)

PLK1 inhibition-based combination therapies for cancer management
por: Su, Shengqin, et al.
Publicado: (2021)

Present and Future Perspective on PLK1 Inhibition in Cancer Treatment
por: Chiappa, Michela, et al.
Publicado: (2022)

Molecular Targeting of the Oncoprotein PLK1 in Pediatric Acute Myeloid Leukemia: RO3280, a Novel PLK1 Inhibitor, Induces Apoptosis in Leukemia Cells
por: Wang, Na-Na, et al.
Publicado: (2015)

Dual Targeting of EGFR with PLK1 Exerts Therapeutic Synergism in Taxane-Resistant Lung Adenocarcinoma by Suppressing ABC Transporters
por: Shin, Sol-Bi, et al.
Publicado: (2021)

Sequencing and phasing cancer mutations in lung cancers using a long-read portable sequencer
por: Suzuki, Ayako, et al.
Publicado: (2017)

Identification and assessment of PLK1/2/3/4 in lung adenocarcinoma and lung squamous cell carcinoma: Evidence from methylation profile
por: Deng, Sisi, et al.
Publicado: (2021)

PLK1 inhibition enhances temozolomide efficacy in IDH1 mutant gliomas
por: Koncar, Robert F., et al.
Publicado: (2017)

CircKPNB1 mediates a positive feedback loop and promotes the malignant phenotypes of GSCs via TNF-α/NF-κB signaling
por: Jiang, Yang, et al.
Publicado: (2022)

Self-regulated mechanism of Plk1 localization to kinetochores: lessons from the Plk1-PBIP1 interaction
por: Lee, Kyung S, et al.
Publicado: (2008)

A missense mutation in solute carrier family 12, member 1 (SLC12A1) causes hydrallantois in Japanese Black cattle
por: Sasaki, Shinji, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_3upd6rsvid0jqg8aglg24qg1f6